• TapImmune and Marker Moving Ahead on Merger with Goal of Creating New Immuno-Oncology Platform
  • Adcetris-Dacarbazine Combo is Effective in Elderly Hodgkin’s Patients, Study Finds
  • Arranon Add-on Improves Long-term Outcomes in Young Patients with T-cell Cancers, Trial Shows
  • 1st Mantle Cell Lymphoma Patient Dosed in Phase 1/2 Trial Testing Cirmtuzumab-Imbruvica Combo
  • ‘Social Network’ of Genes May Help Identify New Therapy Targets for Lymphoma, Other Cancers
  • Young Cancer Survivors Show Signs of Accelerated Aging, Study Finds
  • Zevalin Plus Aggressive Chemotherapy Safe, Effective for Follicular Lymphoma, Phase 2 Trial Shows
  • Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study
  • UK Agency Recommends 3 New Blood Cancer Therapies, Including Adcetris for Lymphoma
  • I’ve Seen the Impact of Cancer Research
  • Gift of Life Marrow Registry Helps California Dad with Leukemia
  • Forty Seven’s 5F9 Immunotherapy on FDA Fast Track for DLBCL, Follicular Lymphoma